Anika acquires two implant companies – Arthrosurface for $100M and Parcus Medical for $95M

websites - Anika Arthrosurface Parcus Medical

Viscosupplementation injections are on the decline by 5% per year. In a bold strategic move, Anika is jumping into implants for joint arthritis and sports medicine for $195M. This will be very interesting to watch. Anika is a public company - ANIK.
The Arthrosurface acquisition is for an upfront payment of around $60 million, with an additional $40 million contingent upon achievement of certain regulatory and commercial milestones.
The Parcus Medical acquisition is for an upfront payment of approximately $35 million in cash, with an a...